Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
360
-
Total 13F shares, excl. options
-
42.1M
-
Shares change
-
-993K
-
Total reported value, excl. options
-
$4.76B
-
Value change
-
-$111M
-
Put/Call ratio
-
0.72
-
Number of buys
-
166
-
Number of sells
-
-154
-
Price
-
$113.15
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q2 2018
410 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q2 2018.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 360 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.1M shares
of 44.8M outstanding shares and own 94.06% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.03M shares), VANGUARD GROUP INC (3.71M shares), FMR LLC (3.52M shares), AQR CAPITAL MANAGEMENT LLC (2.09M shares), STATE STREET CORP (1.99M shares), Palo Alto Investors LP (1.63M shares), RENAISSANCE TECHNOLOGIES LLC (1.56M shares), ACADIAN ASSET MANAGEMENT LLC (1.15M shares), DIMENSIONAL FUND ADVISORS LP (991K shares), and GOLDMAN SACHS GROUP INC (921K shares).
This table shows the top 360 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.